Diabetes & Diabetic Wound
MSC transplantation in newly diagnosed type-1 diabetes patients
Let's take a look at the attached clinical summary, which highlights the promise of mesenchymal stem cells (MSCs) transplantation in patients newly diagnosed with Type-1 diabetes.🩸 This study shows that the intervention has led to improvements in the levels of glycated hemoglobin (HbA1c) and the patient's overall quality of life. Additionally, there are some other positive outcomes worth noting with early transplantation.💫
Prevention of chronic diabetic in type 1 diabetes by co-transplantation of UC-MSC & autologous-BM
Diabetic foot ulcers (DFUs) are serious complications of diabetes mellitus (DM), and their treatment remains challenging, often leading to amputations. However, a study on the implantation of mesenchymal stem cells (MSCs) cultured in scaffolds, as reported in this journal, was found to accelerate wound healing with thicker granulation and increased vascularization.💁🏻♀️ Doesn't that sound promising?
Comparison of BM-MSC with BM-d mononuclear-C for diabetic critical limb ischemia and foot ulcer
Diabetic foot ulcers (DFUs) are serious complications of diabetes mellitus (DM), and their treatment remains challenging, often leading to amputations. However, a study on the implantation of mesenchymal stem cells (MSCs) cultured in scaffolds, as reported in this journal, was found to accelerate wound healing with thicker granulation and increased vascularization.💁🏻♀️ Doesn't that sound promising?
The healing effect of Wharton's jelly MSC seeded on biological scaffold in chronic skin ulcers
☀️ Kickstart the day with a more promising study of stem cells on diabetic wound! 💥 In this clinical study, researchers have made a remarkable discovery: Seeding Wharton's Jelly Stem Cells (WJSCs) on a biological scaffold in chronic skin ulcers significantly enhanced the efficiency of transplanted cells in the tissue healing process!
Safety and efficacy of intramuscular HP-derived mesenchymal stromal-like cells
Here's an attached study that shows intramuscular human placenta mesenchymal stromal-like cells effectively heal ulcers in patients who have diabetic foot ulcers with peripheral arterial disease. Check it out!
HUC-MSC Transplantation After Angioplasty For Diabetic Foot
Discover the advancement in treating diabetic foot ulcers with human umbilical cord mesenchymal stem cells (HUCMSCs). This study highlights significant improvements in skin temperature, ankle-brachial index, and ulcer healing post-angioplasty with HUCMSC transplantation. ✨💫
Targeting Nonhealing Ulcers Of Lower Extremity Through Autologous BM-dMSC
Discover how autologous bone marrow-derived mesenchymal stem cells (BM-MSCs) are revolutionizing the treatment of nonhealing chronic ulcers. This study demonstrates significant improvements in ulcer size reduction and pain-free walking distance, without adverse effects.
Placenta-Derived Mesenchymal Stem Cells Hydrogel In A Patient With Diabetic Foot Ulcer
This study highlights the promising effects of PDMSCs hydrogel, accelerating wound healing, reducing ulcer size, and preventing amputation in a diabetic patient. 🦵🙅♀️ With its unique healing mechanisms, this innovative approach marks the first successful application of PDMSCs hydrogel for diabetic foot ulcers. ✨